The Analyst Verdict: Doximity In The Eyes Of 9 Experts

Ratings for Doximity DOCS were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for Doximity, revealing an average target of $69.67, a high estimate of $90.00, and a low estimate of $43.00. Witnessing a positive shift, the current average has risen by 22.46% from the previous average price target of $56.89.

Diving into Analyst Ratings: An In-Depth Exploration

A comprehensive examination of how financial experts perceive Doximity is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

| Analyst | Analyst Firm | Action Taken | Rating |Current Price Target| Prior Price Target | |--------------------|--------------------|---------------|---------------|--------------------|--------------------| |Jailendra Singh |Truist Securities |Lowers |Hold | $58.00|$65.00 | |Steven Valiquette |Mizuho |Raises |Neutral | $65.00|$55.00 | |David Roman |Goldman Sachs |Raises |Neutral | $80.00|$58.00 | |Michael Cherny |Leerink Partners |Raises |Outperform | $90.00|$60.00 | |Richard Close |Canaccord Genuity |Raises |Hold | $71.00|$60.00 | |Brian Peterson |Raymond James |Raises |Outperform | $83.00|$65.00 | |Stan Berenshteyn |Wells Fargo |Raises |Equal-Weight | $55.00|$43.00 | |Scott Berg |Needham |Raises |Buy | $82.00|$65.00 | |Stan Berenshteyn |Wells Fargo |Raises |Equal-Weight | $43.00|$41.00 |

Key Insights:

• Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Doximity. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Doximity compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Doximity's stock. This examination reveals shifts in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Doximity's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Doximity analyst ratings.

About Doximity

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Unraveling the Financial Story of Doximity

Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.

Revenue Growth: Over the 3M period, Doximity showcased positive performance, achieving a revenue growth rate of 24.63% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 44.6%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Doximity's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.55% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Doximity's ROA stands out, surpassing industry averages. With an impressive ROA of 6.57%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Doximity's debt-to-equity ratio is below the industry average at 0.01, reflecting a lower dependency on debt financing and a more conservative financial approach.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.